Benitec Biopharma Inc. (BNTC): Price and Financial Metrics
BNTC Price/Volume Stats
| Current price | $16.00 | 52-week high | $16.90 |
| Prev. close | $15.17 | 52-week low | $5.74 |
| Day low | $15.10 | Volume | 63,784 |
| Day high | $16.61 | Avg. volume | 41,755 |
| 50-day MA | $13.75 | Dividend yield | N/A |
| 200-day MA | $11.60 | Market Cap | 420.00M |
BNTC Stock Price Chart Interactive Chart >
Benitec Biopharma Inc. (BNTC) Company Bio
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy and chronic hepatitis B virus infection. The company was founded in 1995 and is headquartered in Hayward, California.
BNTC Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BNTC Price Returns
| 1-mo | 18.17% |
| 3-mo | 23.17% |
| 6-mo | 42.48% |
| 1-year | 113.90% |
| 3-year | -3.49% |
| 5-year | -86.57% |
| YTD | 26.68% |
| 2024 | 291.02% |
| 2023 | 11.76% |
| 2022 | -93.51% |
| 2021 | -12.67% |
| 2020 | -60.78% |